Minerva Neurosciences, Inc. (NERV)
2.42
+0.12
(+5.22%)
USD |
NASDAQ |
Nov 06, 16:00
2.415
0.00 (0.00%)
After-Hours: 20:00
Minerva Neurosciences Total Long Term Debt (Quarterly) : 71.74M for Sept. 30, 2026
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 71.74M |
| June 30, 2026 | 71.74M |
| March 31, 2026 | 64.96M |
| December 31, 2025 | 64.96M |
| September 30, 2025 | 60.00M |
| June 30, 2025 | 60.00M |
| March 31, 2025 | 60.00M |
| December 31, 2024 | 60.00M |
| September 30, 2024 | 60.00M |
| June 30, 2024 | 86.58M |
| March 31, 2024 | 84.27M |
| December 31, 2023 | 82.02M |
| September 30, 2023 | 79.83M |
| June 30, 2023 | 77.74M |
| March 31, 2023 | 75.71M |
| December 31, 2022 | 73.73M |
| September 30, 2022 | 71.81M |
| June 30, 2022 | 69.93M |
| March 31, 2022 | 68.11M |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| Date | Value |
|---|---|
| June 30, 2020 | 0.0163M |
| March 31, 2020 | 0.0644M |
| December 31, 2019 | 0.1112M |
| September 30, 2019 | 0.157M |
| June 30, 2019 | 0.2011M |
| March 31, 2019 | 0.2431M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 1.397M |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 3.963M |
| September 30, 2017 | 5.194M |
| June 30, 2017 | 6.393M |
| March 31, 2017 | 7.560M |
| December 31, 2016 | 8.695M |
| September 30, 2016 | 9.799M |
| June 30, 2016 | 10.10M |
| March 31, 2016 | 10.02M |
| December 31, 2015 | 9.938M |
| September 30, 2015 | 9.858M |
| June 30, 2015 | 9.784M |
| March 31, 2015 | 9.705M |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Heron Therapeutics, Inc. | 148.15M |
| Tonix Pharmaceuticals Holding Corp. | 1.022M |
| Karyopharm Therapeutics, Inc. | 255.12M |
| Corbus Pharmaceuticals Holdings, Inc. | 3.265M |
| Ocugen, Inc. | 4.599M |